Sexual health Flashcards
Discuss gonorrhoea
-Pathogen
-Site (5) and cell type targeted
-Period of incubation
-Symptoms (5)
-Investigations (3)
-Treatment (5)
-Complications (3)
-Follow-up
- Pathogen
-Neisseria gonorrhoea
-Gram negative diplococcus - Site and cell of infection
-Endocervix, rectum, urethra, conjunctiva, pharynx
-Infects collumnar epithelia in mucous membranes - Period of incubation - 3 days
- Symptoms
-50% aSx
-Mucopurulant discharge 50%
-Lower abdo pain 25%
-Dysuria 12%
-IMB and PCB - Investigations
-Vulvovaginal NAAT
-Endocervical swab for microscopy and culture
-Investigate for other STI - Treatment
-Ceftriaxone 500mg IM stat
-Given 40% coinfection with chlamydia also treat with:
-Doxycycline 100mg BD 7/7 or Azithromycin 1g Stat
-No unprotected intercourse 7 days
-Contact tracing 3 months
-Notify MOH - Complications
-PID <10%
-Haematogenous spread to skin and joints - arthritis and tenosynovitis
-Disseminated infection - rare - Follow-up
-Contact tracing done
-Ensure not reinfection may require retreatment
-Reinfection common. Offer sexual health check in 3/12
-Test for cure only if symptoms don’t resolve
Discuss gonorrhoea in pregnancy
-Complications to neonate (6)
-Complications to mother (1)
-Risk of transmission
-Who to test
-When to follow-up
Notify MOH for any infection in neonate
1. Complications regarding neonate
-Gonococcal ophthalmia - within 21 days
-Disseminated gonococcal infection - 7-28 days
-Scalp abscess if FSE used
-Septic abortion
-PPROM
-PTL
2. Complications for mother
-Endometritis
3. Risk of transmission
-30-50%
4. Who to test
-Those with sx, at high risk STI, contact with known case
5. Follow-up
-Review after 1 week
-Test of cure only if symptoms do not resolve in a week
Discuss trichomonas
-Pathogen
-Symptoms (6)
-Investigations
-Management
-Follow-up
-Complications
- Pathogen
-Flagellates protozoa - trichomonas vaginalis
-Sexually transmitted
-Incubation period 5-28 days - Symptoms
-Asx - 50%
-Frothy yellow discharge - 10-30%. 70% vaginal discharge
-Classic strawberry cervix - 2%
-Vaginal puritis, vulvitis, vaginitis - Investigations
-NAAT - 10% sensitivity
-Culture or wet slide
-Check for BV - 60-80% co-existant - Management
-Metronidazole 2g stat or 400mg BD 7 days
-Avoid unprotected sex 1/52 from start of treatment
-Partner notification - Follow-up
-Chance of re-infection
-Test of cure only if symptomatic - Complications
-Enhanced HIV transmission
What are the complications to pregnancy associated with trichomonas infection
-Complications to pregnancy (3)
-Complications for neonate (1)
- PPROM, PTD, LBW
- Neonatal vulvoaginitis - 5%, respiratory infection
Discuss chlamydia
-Pathogen
-Sites and cells infected
-Incubation period
-Symptoms (4)
-Investigations
-Management
-Follow-up
-Complications (4)
- Pathogen
-Chlamydia trachomatis
-Gram negative
-Different subtypes - A-C = conjunctivits, D-K = genital L1-L3 = lymphogranuloma venerum - Site and cell
-Obligate intracellular
-Infects cervix, urethra, rectum, conjunctiva, pharynx - Incubation period = 1 day to 6 weeks
- Symptoms
-Asx - 70%
-PCB or IMB
-Purulent discharge
-Dysuria - NAAT - 95% sensitivity. Remains + up to 5 weeks post Rx
- Management
-Firstline doxycycline 100mg PO BD 7/7
-Azythromycin 1g Stat
-Erythromycin 500mg PO BD 7/7 if pregnant
-Partner notification 3/12
-Abstain from sex 1 week from start of treatment - Follow-up
-Test for cure if ongoing symptoms or pregnant - 6 weeks post Rx - Complications
-PID 10-40% if untreated
-Fitz-Hugh-Curtis
-Chronic pelvic pain
-Reiters syndrome - reactive arthritis, urethritis, uveitis
Discuss complications of chlamydia associated with pregnancy
-Complications to pregnancy (5)
-Complications to neonate (3)
- Complications to pregnancy
-Tubal infertility
-Ectopic pregnancy
-No impact on early pregnancy loss
-PPROM
-LBW - Complications to neonate
-Conjunctivitis - 50%
-Pneumonia - 10-20%
-Asx vaginal or rectal infection 15%-
Discuss Lymphogranuloma venereum
-Pathogen
-Site of infection
-Stages of disease
-Management
- Pathogen
-Chlmaydia trichomatis serovars L1-L3 - Site of infection - lymphatic tissue
- Stages of disease
-Primary infection - small painless papules, pustules or ulcers.
-Secndary infection - lymphadenopathy, malaise, fever, joint and muscle aches
-Late phase - abscess,lymphatic obstruction, genital oedema - Management
-Doxycycline for at least 3/52
What are the causes of genital ulcers
-Infectious causes
-Sexually transmitted (6)
-Not sexually transmitted (7)
-Non infectious causes (4 groups)
- Sexually transmitted infectious cause of genital ulcers
-HSV 1-2 small blisters which form red based painful ulcers
-Syphillis - single painless ulcer with clean base and firm edges
-Gono/Trich
-Lymphogranuloma venereum - single painless ulcer
-Chancroid - unilateral papule that becomes pustular an dulcerates with yellow discharge
-Donovanosis/ Granuloma inguinale - chronic red indurated painless ulcer - Non-sexually transmitted
-Candidiasis - severe
-Herpes zoster
-TB
CMV
-EBV
-Mycoplasma
-Group A strep - Non infectious causes of genital ulcers
-Apthous ulcers - painful punched out ulcers, yellow/white base with red boarder. Due to autoimmune, spontaneous, post infection (EBV) trauma
-Inflammatory causes - dermatitis, lichen planus etc
-Blistering - pemphigus vulgaris, erythema multiforme
-Malignant - Vulval SCC, VIN, BCC
How should genital ulcers be investigated? (5)
Investigations:
1. Viral swab - HSV 1+2
2. NAAT for chlamydia/Trich/Gono
3. Serology for syphillis, HIV, Hep B+C, HSV, EBV, CMV
4. ANA if concerned for autoimmune
5. Biopsy if dx cannot be made or suspect malignancy
Discuss herpes
-Incidence
-Symptoms - primary and secondary
-Investigations
- Incidence
-20% of adults have HSV-2 - Symptoms
-25% Asx, 50% mild sx, 25% modreate to severe sx
-Primary sx
-Fever, Malaise, myalgia
-Dysuria, vaginal discharge, painful ulceration, lymphadenopathy
-Secondary sx
-Asx, ulcers - usually less painful, prodromal sx such as tinglind - Investigations
-Viral swab of base for PCR. Neg result doesn’t exclude infection
-HSV serology - not routine as not accurate.
-Only indicates past infection
-Not all people sertoconvert
-Doesn’t distinguish site
-Perform if suspect primary infection in pregnancy
-Syphillis serology
Discuss the pathophysiology of HSV 1
-Area infects
-Transmission
-Asymtpomtic sheadding risk
-Risk of recurrence
- Infects genitals and oral areas
- Transmission through oral genital contact
- Less asymptomatic sheeding cf HSV 2
- Fewer clinically apparent recurrences cf HSV 2
Discuss the pathophysiology of HSV 2
1. Site of infection
2. Incubation period
3. Transmission
4. Asymptomatic shedding risk
5. Risk of recurrence and causes
- Genital area
- Incubation period 1-2 weeks
- Transmitted genital to genital
- More asymptomatic shedding cf HSV 1. More common if HIV+, more common in first 12 months post primary infection
- More recurrence - 4 per year cf HSV 1
- Cause of recurrence - stress, menstruation, UV light
Discuss the management of herpes
-Reduction of transmission
-General principles
-Medication regimens
-Secondary prevention
- Reduction in transmission
-Condoms - not 100% effective
-Avoid sexual intercourse when active lesions
-Suppression with antivirals - reduces asymptomtic shedding 80-95% - General principles
-Patient education
-Psychological - referral for counselling if needed
-Sits baths
-Analgesia - topical and oral. Cold compress
-IDC or void in bath if urinary retention
-Loose clothing
-Full sexual health screen
-Partner notification - Antivirals
-Give regardless of time of onset
-Valciclovir 500mg PO BD 7/7
-Aciclovir 400mg PO TDS 7/7 - Secondary prevention
-Avoid triggers
-Avoid tampons when symptomatic
-Consider menstrual suppression if a tripper
-Episodic treatment - valciclovir 500mg PO BD 3/7 or Aciclovir 800mg PO TDS 2/7
-Suppressive continuous treatment - 500mg PO OD valciclovir or 400mg PO OD aciclovir. Reassess at 1 yr
Describe the pathophysiology of HIV/AIDS
-Transmission
-Cell invasion
-Replication
-AIDS defining illnesses (5)
- Transmission by: sex, vertical, parenteral
- HIV invades T cells through CD4 receptor and co-receptor
- Replication
-Uses reverse transcriptase to change from viral RNA to proviral DNA.
-Inserts into host DNA
-T cells apoptose on viral spread - AIDS defining illnesses
-Kaposi sarcoma
-Oesophageal candidiasis
-Pneumocystis Jiroveci pneumonia
-Cerebral toxoplasmosis
-HIV encephalopathy
Discuss HIV
-Presentation
-Investigations
- Presentation
-Acute infection - flu like illness - malaise, lymphadenopathy, pharyngitis, rash
-Development of antibodies to core protiens p24 and surface protiens GP 41, 120, 160 - Chronic infection
- Asx until CD4 count decreases
- B symtpoms - night sweats, fevers, weight loss, diarrhoea
- Increase in opportunistic infections - TB, CMV retinitis, PCP - Investigations
-Pretest counselling important
-Enzyme immunoassay for antibodies
-PCR for viral RNA
-Full sexual health screen
Discuss management of HIV
-Reduction of transmission (6)
-Antivirals
- Reduction of transmission
-Condom use - almost 100% effective
-Reduce viral load to undetectable
-PrEP - pre exposure prophylaxis - Truvada
-PEP - post exposure prophylaxis - Triple HAART within 72hrs for 1 month
-Antenatal screening and treatment for mother and baby
-Partner notification - Antiviral treatment
-Treat if symptomatic or CD4 count <350
-Use triple therapy
-Neocleoside reverse transcriptaase inhibitor, non-neucleoside reverse transcriptase inhibitor, Protease inhibitors.
-HAART toxic - peripheral neuropathy, lactic acidosis, hepatitis, pancreatitis
-Aim for viral load <50
Discuss HPV (Human papillomavirus)
-Relation to cervical cancer
-Prevalance
-Association with other cancers (6)
- HPV causes 99.7% of cervical cancers
- Prevalence
-80% of sexually active adults will acquire HPV
-80% of people clear HPV, 20% it is persisitent
-Higher prevalnce but faster clearence in women <20yrs - Associated with following cancers
-Vulval, vaginal, penis, anus, head and neck